Aesculap AG - Global Leader in Surgical Technology and Medical Devices

Company Profile (Updated April 2026)

Aesculap AG is a globally renowned German medical technology company and the dedicated Surgical Division of the B. Braun Group, specializing in the development, manufacturing, and distribution of high-precision surgical instruments, implants, and comprehensive solutions for surgery and orthopedics. Established in 1867 by Gottfried Jetter in Tuttlingen, Baden-Württemberg, Germany, Aesculap has evolved from a small cutlery workshop into one of the world's largest and most respected manufacturers of surgical equipment, maintaining its headquarters in Tuttlingen for over 150 years.

The company became part of the B. Braun family in 1976 when B. Braun acquired a controlling interest, and was fully incorporated as the Aesculap Division in 1998. Today, Aesculap represents the surgical and interventional core of B. Braun's global healthcare empire, employing approximately 12,400 people worldwide and generating €2.374 billion in annual revenue for 2025 (representing a 3.3% increase year-over-year, or 5.4% at constant exchange rates). The Tuttlingen headquarters remains the largest employer in the city with around 3,400 employees, operating state-of-the-art production facilities including a recently commissioned 1,200m² cleanroom for sterile surgical instrument manufacturing.

Corporate History & Evolution

Founded: 1867 by Gottfried Jetter (qualified cutler) in Tuttlingen, Germany
   Key Milestones:

- 1887: Renamed Jetter & Scheerer after Karl-Christian and Wilhelm Scheerer (Jetter's brothers-in-law) joined as partners
   - 1889: Established the iconic Aesculap trademark (staff of Aesculapius with serpent and crown); opened first branch in Berlin followed by international offices in New York, London, Paris, Constantinople, Buenos Aires, and Tokyo
   - 1895: Incorporated as Aktiengesellschaft für Feinmechanik vormals Jetter & Scheerer
   - 1900: AESCULAP officially registered as trademark
   - 1935: Invented the first surgical electric motor
   - 1967: Developed the first pneumatic surgical motor
   - 1976: B. Braun acquired controlling interest in Aesculap AG
   - 1972: Established production site in Penang, Malaysia
   - 1995: Founded Aesculap Akademie in Tuttlingen
   - 1998: Fully incorporated into B. Braun Group as Aesculap Division
   - 2024: Generated €2.298 billion in revenue (solid organic growth)
   - 2025: Celebrated 30 years of Aesculap Academy; opened new 1,200m² ISO Class 7/8 cleanroom; completed True Digital Surgery acquisition; achieved €2.374 billion revenue

Parent Company: B. Braun Melsungen AG (since 1976)
   CEO (B. Braun): Anna Maria Braun
   Headquarters: Am Aesculap-Platz, 78532 Tuttlingen, Germany
   Global Employees: ~12,400 (Aesculap Division); ~3,400 at Tuttlingen headquarters
   2024 Revenue: €2.298 billion
   2025 Revenue: €2.374 billion (+3.3% reported, +5.4% constant currency)
   Website: www.aesculap.com / www.bbraun.com

Revolutionary Product Portfolio

Surgical Instruments

Aesculap manufactures over 18,000 finished products and 29,000 semi-finished products across three main categories at its Tuttlingen facility:

- Handheld Surgical Instruments: Scalpels, scissors, forceps, needle holders, retractors, curettes, periosteal elevators, and microsurgical instruments manufactured from premium surgical steel and titanium

- Sterile Container Systems: Advanced rigid sterile containers for surgical instrument storage and reprocessing (produced in Suzhou, China - 1 million units annually - and Tuttlingen)

- Motor Systems: Battery-powered surgical motors for operating theaters including the Aesculap Aeos digital surgical microscope system (enhanced through True Digital Surgery acquisition)

Neurosurgery

Comprehensive portfolio for neurosurgical interventions:

- AVM Microclip Applying Forceps: Specialized instruments for arteriovenous malformation treatment

- Bipolar Coagulation Forceps: Precision electrosurgical instruments for neurosurgical procedures

- Aneurysm Clips and Cranial Fixation Systems: Critical implants for neurovascular surgery

- Lyoplant Onlay: AbsorbAble dural substitute for dura mater repair (CE marked, widely recognized for ease of use and reliable performance)

- Hydrocephalus Shunts and Neuroendoscopy Equipment: Advanced solutions for CSF management and minimally invasive neurosurgery

Orthopedics and Spine

Aesculap has been a pioneer in orthopedic implants since the mid-20th century:

- Joint Replacement: Hip and knee prostheses with precise fitting technology

- Spine Surgery: Comprehensive portfolio for spinal stabilization and fusion, including cervical retractors (modular systems expanded in 2022)

- Osteosynthesis: Plates, screws, and systems for fracture fixation

Electrosurgery and Energy Systems

Aesculap is a major player in the global electrosurgical generator market:

- High-Frequency Electrotome (ESU): Electrosurgical generator units for cutting and coagulation

- CVS 300 Electrosurgery System: Advanced vessel sealing technology for laparoscopic and open surgery

Vascular and Interventional Systems

- SeQuent Please ReX: Drug-coated PTCA balloon catheter for coronary in-stent restenosis (FDA IDE trial collaboration with Infraredx/Nipro since 2024)

- Fantom Encore: Bioresorbable scaffold for coronary interventions (distributed in Germany and Switzerland through partnership with REVA Medical since November 2024)

Award-Winning Innovations (2025)

Red Dot Design Award 2025: Aesculap received this prestigious recognition for:

- Aesculap SQ.line Laparoscopic Clip Appliers: Ergonomic, precision-designed instruments for minimally invasive abdominal surgery

- Aesculap SQ.line KERRISON Bone Punches: Advanced spinal and neurosurgical instruments for bone removal with enhanced safety and control

Manufacturing Excellence and Quality Standards

Vertical Integration: Aesculap maintains one of the highest levels of vertical integration in the medical device industry, performing everything from laser marking, welding, cleaning, bending, punching, and cutting in-house. The company operates 15 TruMark and ten TruMicro Mark lasers for marking alone at its Tuttlingen facility.

Global Production Network:

- Germany (Tuttlingen): Headquarters and primary manufacturing for surgical instruments, implants, and motors; features new 1,200m² ISO Class 7/8 cleanroom (2025) for final production of sterile surgical instruments and neurosurgical implants

- china (Suzhou): Produces 1 million surgical instruments annually including bone punches, forceps, scissors, and sterile containers

- Malaysia (Penang): Established 1972, producing surgical instruments

- USA (Center Valley, PA): Aesculap Inc. serving North American market since 1977

- France and other locations: Additional manufacturing and distribution centers

Recent Strategic Developments (2024-2026)

Digital Transformation:

- December 2025: B. Braun completed the acquisition of True Digital Surgery, establishing the Goleta site as a new Technology Innovation Center to enhance Aesculap's digital microscopy capabilities and expand market share in digital microsurgery

- September 2024: B. Braun received ISO 27001 certification for information security, ensuring robust protection of sensitive patient and health-related data across digital systems

Product Innovation:

- September 2024: Launched CARESAFE IV administration sets - the first robust PVC-free and DEHP-free IV administration set portfolio, protecting both environment and patients from toxic substance exposure while preventing air infusion risks

- December 2024: Released next-generation OnGuard 2 closed system transfer device (CSTD) with enhanced material compatibility for hazardous drugs and extended microbial ingress claims

- July 2025: SQ.line series received Red Dot Design Awards for outstanding product design and ergonomics

Facility Expansion:

- May 2025: Commissioned the largest and most modern cleanroom facility at Tuttlingen headquarters (1,200m², ISO Class 7/8) for final production of sterile surgical instruments and neurosurgical implants, representing significant investment in manufacturing capabilities

Global Market Presence

Geographic Reach: Aesculap operates in over 60 countries through the B. Braun global network, with primary markets including:

- Europe: Strong presence in Germany, France, UK, Italy, Spain, Scandinavia, and Eastern Europe (CE-marked products)

- North America: Established market through Aesculap Inc. (USA since 1977); expected to grow significantly above segment average in 2026

- Asia-Pacific: Major production in China and Malaysia; growing markets in Japan, Australia, and emerging Asian economies

Key Market Performance (2025): Growth driven by solid organic expansion in established markets, with particular strength in Europe and the USA. The company successfully navigated market challenges while maintaining growth above industry averages.

Aesculap Academy: Global Education Leadership

Since its founding in 1995, the Aesculap Academy has served as B. Braun's premier education forum, attracting over 2 million participants worldwide by 2025. The Academy offers comprehensive training programs for surgeons, nurses, and healthcare professionals across multiple disciplines including neurosurgery, orthopedics, vascular surgery, and general surgery. This commitment to education reflects Aesculap's core philosophy of "Sharing Expertise" and ensures optimal clinical outcomes through proper product utilization and advanced surgical technique training.

2026 Outlook & Strategic Vision

Growth Projections: Aesculap is forecast to achieve growth above the Group average in the 2026 fiscal year, with all regions contributing to this expansion. The USA market is expected to grow significantly more than the segment average, driven by enhanced digital surgery capabilities and strong demand for surgical technologies.

Digital Surgery Expansion: Integration of True Digital Surgery's advanced microscopy and imaging technologies into Aesculap's portfolio, driving the transition toward digital and minimally invasive surgical solutions through the new Goleta Technology Innovation Center.

Manufacturing Excellence: Continued investment in state-of-the-art production facilities including cleanroom technology and automated manufacturing systems to maintain highest quality standards while scaling capacity.

Regulatory and Environmental Leadership: Expansion of PVC-free and environmentally sustainable product lines (CARESAFE initiative) while maintaining compliance with evolving EU Medical Device Regulations (MDR).

Innovation Pipeline: Continued development in bioresorbable scaffolds (Fantom Encore partnership), drug-coated balloons for cardiovascular applications, and next-generation electrosurgical technologies.

Global Education: Expansion of Aesculap Academy programs to address growing demand for specialized surgical training in emerging markets, building on the 30-year legacy of training over 2 million healthcare professionals.

Contact Information

Global Headquarters

Company: Aesculap AG
   Address: Am Aesculap-Platz, 78532 Tuttlingen, Germany
   Phone: +49 (0) 7461 95-0
   Fax: +49 (0) 7461 95-26 00
   Email: info@aesculap.de
   Website: www.aesculap.com / www.bbraun.com

Regional Offices

USA (Aesculap Inc.): Center Valley, Pennsylvania
   Americas Headquarters: B. Braun of America
   Production Sites: Tuttlingen (Germany), Penang (Malaysia), Suzhou (China), France, USA

Keywords: Aesculap AG,蛇牌,B Braun,surgical instruments,neurosurgery,orthopedic implants,spine surgery,electrosurgery,sterile containers,Tuttlingen,Germany,1867,Gottfried Jetter,Aesculap Academy,Lyoplant,SQ line,Red Dot Design Award,True Digital Surgery,Goleta Innovation Center,30 years Academy,12,400 employees,2.374 billion EUR revenue,2025 revenue,ISO 27001,cleanroom manufacturing